Caplin Point Laboratories Limited (BSE: 524742)
Health Care · Pharmaceuticals · IN
Rs2,459.55
-6.56% today · +19.7% 1Y
Caplin Point Laboratories Limited (BSE: 524742) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.93B.
Over the last twelve months the share price has gained 19.7%, trading between 1.50K and 2.99K.
Tweenvest scores Caplin Point Laboratories Limited across four factors: quality 88/100, value 17/100, growth 75/100, dividend 75/100. Its strongest factor is quality.
524742 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.93B
- Revenue (TTM)
- $241.91M
- P/E
- 28.18
- EPS
- 87.29
- Dividend yield
- 0.33%
- Beta (5Y)
- 0.42
- 52-week high
- Rs2,990.60
- 52-week low
- Rs1,502.45
- Avg volume (3M)
- —
- Shares outstanding
- 76.01M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| PT Kalbe Farma Tbk.IDX: KLBF | $1.99B | Rp785.00 | +8.28% |
| Trulieve Cannabis Corp.NYSE: TRLV | $1.98B | $10.30 | +3.31% |
| Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.SHSE: 603707 | $1.97B | CN¥8.18 | -0.12% |
| Shenzhen Hepalink Pharmaceutical Group Co., Ltd.SZSE: 002399 | $1.95B | CN¥9.89 | +0.41% |
| Porton Pharma Solutions Ltd.SZSE: 300363 | $1.90B | CN¥23.68 | -3.58% |
| Beijing Aosaikang Pharmaceutical Co., Ltd.SZSE: 002755 | $1.85B | CN¥13.34 | -1.55% |
| Pfizer LimitedNSEI: PFIZER | $1.84B | Rs3,810.80 | -2.91% |
| Xeris Biopharma Holdings, Inc.NasdaqGS: XERS | $1.84B | $10.07 | +3.07% |
Figures last refreshed Oct 11, 2026.